In some ways, Mohawk’s SmartStrand triexta carpet is in a similar situation ... and when reclaimed it has no substantial existing end-use markets. PTT volume in the waste stream isn’t ...

A range of processing technologies and end-use markets have been developed through ... there’s a different polyester, PTT or triexta, that has carved out a strong niche in the residential ...

The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...

We may earn a commission from links on this page. The Thurston County Sheriff’s Office proudly posted the pursuit footage on its Facebook page. The chase took place on the winding two-lane ...

Another November brings another report by the state Opioid Settlement Fund Advisory Board, a group of experts brought together to recommend how New York State should allocate the hundreds of ...

But the duo still chose to include a disclaimer in their film's end credits stating that no generative AI was used to make their movie. Beck and Woods, who are best known for writing the ...

Most often, servants or low-ranking people used this to address their elders and superiors. Therefore, by the end of the 19th century, the ‘-s’ particle was perceived negatively, almost as a ...

Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.

ANX005 in Guillain-Barré syndrome (GBS): First-in-kind monoclonal antibody designed to block C1q and the entire classical complement pathway in both the body and the brain has the potential to be the ...